News
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
More in Business
- Pressure on U.S. Treasurys eases after 30-year yield hits highest level since 2002 CNBC — World News
- Greggs to shut four factories and cut 740 jobs BBC News — Business
- Bracing for More Inflation Volatility The New York Times — Business
- ‘I’m afraid of human stupidity’: Why this top economist prefers U.S. tech and gold over bonds MarketWatch
- FlyDubai flight scare: Passengers pray, sing as plane makes emergency landing in Saudi Arabia | Video Mint